Operating income decreased 63.7%
Operating income changed -63.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -63.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed +48.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -610 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -68.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -743.7% from the comparable as-filed period.
Gross profit changed -73.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed -31.5% from the comparable as-filed period.
Research & development changed -24.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.